Evommune, Inc. operates as a clinical-stage biotechnology company in the United States. The company develops therapies that target key drivers of chronic inflammatory diseases, with initial clinical development programs focusing on chronic ...
Q2 2026
Aug 6, 2026
Q1 2026
May 15, 2026
FY 2025
Mar 27, 2026
Q4 2025
Q3 2025
Dec 15, 2025